- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03636178
3D Evaluation of Nasolabial Changes Following Classic Versus Modified Alar Base Suture After Le Fort I Osteotomy
Three Dimensional Evaluation of Nasolabial Changes Following Classic Versus Modified Alar Base Suture After Le Fort I Osteotomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Intra operative procedures: (For all groups) All surgical operations will be performed or supervised by one of the authors (MdK). Intraoperative antibiotics will be given(1000 mg cefazolin and 500 mg metronidazole). After nasotracheal intubation, the mucobuccal fold of the maxilla will be infiltrated with local anaesthetic (articaine ; Ultracain DS Forte). The Le Fort I procedure will be started with an incision in the gingivobuccal sulcus from the canine on the one side to the canine on the other side. After elevation of the mucoperiosteum and nasal mucosa, the osteotomy line will be designed with a fine burr, after which the cut will be made with a reciprocal saw. The lateral nasal walls and nasal septum will be osteotomized with a nasal osteotome. The piriform aperture and when necessary the nasal spine will be rounded off. After mobilization of the maxilla, it will be positioned in the planned position using an acrylic wafer. Fixation will be performed with four 1.5-mm miniplates, one paranasal and one on the buttress on each side. The mucosa will be closed with a 4-0 Vicryl suture (Ethicon ; Johnson and Johnson Medical, Norderstedt, Germany).
The alar cinch procedure will be performed through the intraoral incision as follows:
In the comparator ( control ) group:
The classic method of alar cinching will be performed in the following manner: An index finger will be used to apply extraoral pressure on the alar base region, and a dentate forceps will grasp this tissue through the intraoral incision. A suture bite will be taken at this point through the tissue previously held by the forceps. The same procedure will be applied on the opposite side. After passing the suture on both sides, it will be tightened with attention to the alar base response. If the alar base suture will be judged to be adequate, the vestibular incision will then be closed in a routine fashion, with or without performing a V-Y lip closure.
In the intervention group:
The alar base will be marked with 3 landmarks: the nasofacial skin fold at the left alar base (point LAB), the middle of the columella (point C), and the nasofacial skin fold at the right alar base (point RAB). A needle will be inserted through the skin at the nasofacial skin fold and exited through the fibroareolar tissue. A nonabsorbable suture without a needle will be inserted through the needle from the oral cavity to the outside. The needle will be retracted through point RAB without leaving the skin point, then returned to the oral cavity in a medial position. Finally the needle will be retracted from point RAB, leaving the suture through the soft tissue. The same procedure will be repeated on the other side. The 2 free ends of the sutures will be then tied together after passing through a hole made in the nasal spine.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients with skeletal maxillomandibular deformity indicated for surgical correction by Le Fort I osteotomy.
- Absence of clefts.
- Absence of growth.
- Patients must be willing for the surgical procedure and follow-up, with his informed consent.
Exclusion Criteria:
- History of facial trauma with fractures of facial bones.
- History of surgical operation in nasal region.
- Facial asymmetry.
- Patients with accompanying craniofacial syndromes.
- Patients with any diseases that compromise bone or soft tissue healing.
- Anterior open bite cases
- Medically compromised patients not fit for general anaesthesia.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: 1st group
20 patients out of 40 will be enrolled into the study including males and females above 18 years old
|
An index finger will be used to apply extraoral pressure on the alar base region, and a dentate forceps will grasp this tissue through the intraoral incision.
A suture bite will be taken at this point through the tissue previously held by the forceps.
The same procedure will be applied on the opposite side.
After passing the suture on both sides, it will be tightened with attention to the alar base response.
If the alar base suture will be judged to be adequate, the vestibular incision will then be closed in a routine fashion, with or without performing a V-Y lip closure
|
Other: 2nd group
20 patients out of 40 will be enrolled in the study including males and females above 18 years old
|
The alar base will be marked with 3 landmarks: left alar base (point LAB), columella (point C), and right alar base (point RAB).
A needle will be inserted through the skin at the nasofacial skin fold and exited through the fibroareolar tissue.
A nonabsorbable suture without a needle will be inserted through the needle from the oral cavity to the outside.
The needle will be retracted through point RAB without leaving the skin point, then returned to the oral cavity in a medial position.
Finally the needle will be retracted from point RAB, leaving the suture through the soft tissue.
The same procedure will be repeated on the other side.
The 2 free ends of the sutures will be then tied together after passing through a hole made in the nasal spine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Widening of the alar base
Time Frame: 6 months postoperatively
|
Postoperative increase in the alar base width in millimeters(mm) in comparison to the normal preoperative alar base width
|
6 months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nasal volume
Time Frame: 6 months postoperatively
|
Postoperative increase or decrease in the nasal volume in cubic millimeters in comparison to the normal preoperative nasal volume
|
6 months postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CEBD-CU-2018-07-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Le Fort; I
-
Hams Hamed AbdelrahmanCompleted
-
Future University in EgyptCompleted
-
Bezmialem Vakif UniversityCompletedMalocclusion | Orthognathic Surgery | Open Bite | Le Fort; ITurkey
-
Alexandria UniversityCompletedDentofacial Deformities | Le Fort; IEgypt
-
Johns Hopkins UniversityRecruiting
-
Chang Gung Memorial HospitalUnknownCleft Lip and Palate | Le FortTaiwan
-
Penumbra Inc.CompletedLower Extremity Acute Limb Ischemia | LE ALIUnited States, Spain, Germany
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompletedBipolar IUnited States, France, Romania, Poland, Canada, Hungary, Japan, Korea, Republic of, Malaysia, Taiwan
-
Solvay PharmaceuticalsWyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/SCompleted
Clinical Trials on Classic alar base suture technique
-
Chang Gung Memorial HospitalCompletedConditions in T74.31 or T76.31Taiwan
-
Inje UniversityCompletedPain | Thyroidectomy | Esthetic | Dermal StaplerKorea, Republic of
-
Selcuk UniversityCompleted
-
Technische Universität DresdenCompleted
-
University of MichiganCompletedHernia | Lung CancerUnited States
-
University of California, DavisCompletedMelanoma | Basal Cell Carcinoma | Squamous Cell CarcinomaUnited States
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Sohag UniversityRecruitingObstructive Sleep ApneaEgypt
-
Kanuni Sultan Suleyman Training and Research HospitalRecruitingUterine Niche | Closure; Incomplete, UterusTurkey
-
Chen XiaopingUnknownPancreaticoduodenectomyChina